N-terminal pro-brain natriuretic peptide as an early prognostic factor in cancer patients developing septic shock

Critical Care

Volumn 11, Issue , 2007, Pages

  Mokart, Djamel ^a   Sannini, Antoine ^a   Brun, Jean Paul ^a   Faucher, Marion ^a   Blaise, Didier ^a   Blache, Jean Louis ^a   Faucher, Catherine ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA LACTAM ANTIBIOTIC; DOBUTAMINE; GLYCOPEPTIDE; NORADRENALIN; PAROMOMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; BRAIN NATRIURETIC PEPTIDE; TROPONIN I;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIASTOLIC DYSFUNCTION; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; SYSTOLIC DYSFUNCTION; TRANSTHORACIC ECHOCARDIOGRAPHY; BLOOD; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; MIDDLE AGED; NEOPLASM; PROSPECTIVE STUDY; ROC CURVE; STATISTICS;

AGED; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; SHOCK, SEPTIC; TROPONIN I;

EID: 39549112287     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc5721     Document Type: Article

References (45)

1. Kress JP Christenson J Pohlman AS Linkin DR Hall JB Outcomes of critically ill cancer patients in a university hospital setting Am J Respir Crit Care Med 1999, 160:1957-1961. 10588613
2. Larche J Azoulay E Fieux F Mesnard L Moreau D Thiery G Darmon M Le Gall JR Schlemmer B Improved survival of critically ill cancer patients with septic shock Intensive Care Med 2003, 29:1688-1695. 10.1007/ s00134-003-1957-y 13680115
3. Regazzoni CJ Irrazabal C Luna CM Poderoso JJ Cancer patients with septic shock: Mortality predictors and neutropenia Support Care Cancer 2004, 12:833-839. 10.1007/s00520-004-0667-5 15309590
4. Vieillard-Baron A Prin S Chergui K Dubourg O Jardin F Hemodynamic instability in sepsis: Bedside assessment by Doppler echocardiography Am J Respir Crit Care Med 2003, 168:1270-1276. 10.1164/rccm.200306-816CC 14644922
5. Parker MM Shelhamer JH Bacharach SL Green MV Natanson C Frederick TM Damske BA Parrillo JE Profound but reversible myocardial depression in patients with septic shock Ann Intern Med 1984, 100:483-490. 6703540
6. Maeder M Fehr T Rickli H Ammann P Sepsis-associated myocardial dysfunction: Diagnostic and prognostic impact of cardiac troponins and natriuretic peptides Chest 2006, 129:1349-1366. 10.1378/chest.129.5.1349 16685029
7. Wiese S Breyer T Dragu A Wakili R Burkard T Schmidt-Schweda S Fuchtbauer EM Dohrmann U Beyersdorf F Radicke D Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length Circulation 2000, 102:3074-3079. 11120697
8. Hobbs FD Davis RC Roalfe AK Hare R Davies MK Kenkre JE Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: Cohort study in representative and high risk community populations BMJ 2002, 324:1498-116449. 12077039 10.1136/bmj.324.7352.1498
9. Dahlstrom U Can natriuretic peptides be used for the diagnosis of diastolic heart failure? Eur J Heart Fail 2004, 6:281-287. 10.1016/ j.ejheart.2004.01.005 14987577
10. Roch A Allardet-Servent J Michelet P Oddoze C Forel JM Barrau K Loundou A Perrin G Auffray JP Portugal H NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients Crit Care Med 2005, 33:1001-1007. 10.1097/01.CCM.0000162561.82012.E9 15891328
11. Sandri MT Salvatici M Cardinale D Zorzino L Passerini R Lentati P Leon M Civelli M Martinelli G Cipolla CM N-terminal pro-B-type natriuretic peptide after high-dose chemotherapy: A marker predictive of cardiac dysfunction? Clin Chem 2005, 51:1405-1410. 10.1373/clinchem.2005.050153 15932966
12. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit Care Med 1992, 20:864-874. 1597042
13. Levy MM Fink MP Marshall JC Abraham E Angus D Cook D Cohen J Opal SM Vincent JL Ramsay G 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Intensive Care Med 2003, 29:530-538. 12664219
14. Dellinger RP Carlet JM Masur H Gerlach H Calandra T Cohen J Gea-Banacloche J Keh D Marshall JC Parker MM Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock Intensive Care Med 2004, 30:536-555. 10.1007/s00134-004-2398-y 14997291
15. Charlson ME Sax FL MacKenzie CR Braham RL Fields SD Douglas RG Jr Morbidity during hospitalization: Can we predict it? J Chronic Dis 1987, 40:705-712. 10.1016/0021-9681(87)90107-X 3110198
16. Le Gall JR Lemeshow S Saulnier F A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study JAMA 1993, 270:2957-2963. 10.1001/jama.270.24.2957 8254858
17. Le Gall JR Klar J Lemeshow S Saulnier F Alberti C Artigas A Teres D The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group JAMA 1996, 276:802-810. 10.1001/jama.276.10.802 8769590
18. Sahn DJ DeMaria A Kisslo J Weyman A Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements Circulation 1978, 58:1072-1083. 709763
19. Schiller NB Shah PM Crawford M DeMaria A Devereux R Feigenbaum H Gutgesell H Reichek N Sahn D Schnittger I Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 1989, 2:358-367. 2698218
20. How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure Eur Heart J 1998, 19:990-1003. 10.1053/ euhj.1998.1057 9717033
21. Galderisi M Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects Cardiovasc Ultrasound 2005, 3:9 1087861 15807887 10.1186/1476-7120-3-9
22. Herrmann Z Uhl W Steinberg HW Dworschack R The influence of renal function on NT-proBNP levels in various disease groups Clin Lab 2003, 49:649-656. 14651336
23. Apple FS Wu AH Jaffe AS European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials Am Heart J 2002, 144:981-986. 10.1067/mhj.2002.124048 12486421
24. Harrell FE Jr Lee KL Matchar DB Reichert TA Regression models for prognostic prediction: Advantages, problems, and suggested solutions Cancer Treat Rep 1985, 69:1071-1077. 4042087
25. Peduzzi P Concato J Kemper E Holford TR Feinstein AR A simulation study of the number of events per variable in logistic regression analysis J Clin Epidemiol 1996, 49:1373-1379. 10.1016/S0895-4356(96)00236-3 8970487
26. Jardin F Dubourg O Bourdarias JP Echocardiographic pattern of acute cor pulmonale Chest 1997, 111:209-217. 8996019
27. Munt B Jue J Gin K Fenwick J Tweeddale M Diastolic filling in human severe sepsis: An echocardiographic study Crit Care Med 1998, 26:1829-1833. 9824075
28. Poelaert J Declerck C Vogelaers D Colardyn F Visser CA Left ventricular systolic and diastolic function in septic shock Intensive Care Med 1997, 23:553-560. 10.1007/s001340050372 9201528
29. Brueckmann M Huhle G Lang S Haase KK Bertsch T Weiss C Kaden JJ Putensen C Borggrefe M Hoffmann U Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis Circulation 2005, 112:527-534. 10.1161/CIRCULATIONAHA.104.472050 16027260
30. Nousiainen T Vanninen E Jantunen E Puustinen J Remes J Rantala A Hartikainen J Concomitant impairment of left ventricular systolic and diastolic function during doxorubicin therapy: A prospective radionuclide ventriculographic and echocardiographic study Leuk Lymphoma 2002, 43:1807-1811. 10.1080/1042819021000006439 12685836
31. Ammann P Fehr T Minder EI Gunter C Bertel O Elevation of troponin I in sepsis and septic shock Intensive Care Med 2001, 27:965-969. 10.1007/ s001340100920 11497154
32. Tomaru KK Arai M Yokoyama T Aihara Y Sekiguchi KK Tanaka T Nagai R Kurabayashi M Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes J Mol Cell Cardiol 2002, 34:649-659. 10.1006/ jmcc.2002.2005 12054852
33. Maisel AS McCord J Nowak RM Hollander JE Wu AH Duc P Omland T Storrow AB Krishnaswamy P Abraham WT Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study J Am Coll Cardiol 2003, 41:2010-2017. 10.1016/S0735-1097(03)00405-4 12798574
34. Charpentier J Luyt CE Fulla Y Vinsonneau C Cariou A Grabar S Dhainaut JF Mira JP Chiche JD Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis Crit Care Med 2004, 32:660-665. 10.1097/01.CCM.0000114827.93410.D8 15090944
35. Jardin F Brun-Ney D Auvert B Beauchet A Bourdarias JP Sepsis-related cardiogenic shock Crit Care Med 1990, 18:1055-1060. 10.1097/ 00003246-199010000-00001 2209030
36. Vieillard BA Schmitt JM Beauchet A Augarde R Prin S Page B Jardin F Early preload adaptation in septic shock? A transesophageal echocardiographic study Anesthesiology 2001, 94:400-406. 10.1097/ 00000542-200103000-00007 11374597
37. Rumoroso JR Montes PM Garcia JC Arrizabalaga JI Arana JI Barrenetxea JI [Acute right ventricular insufficiency reversible following anthracycline treatment] Rev Esp Cardiol 1995, 48:205-207. 7701103
38. Bossone E Bodini BD Mazza A Allegra L Pulmonary arterial hypertension: the key role of echocardiography Chest 2005, 127:1836-1843. 10.1378/ chest.127.5.1836 15888866
39. Kerbaul F Rondelet B Motte S Fesler P Hubloue I Ewalenko P Naeije R Brimioulle S Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure Crit Care Med 2004, 32:1035-1040. 10.1097/01.CCM.0000120052.77953.07 15071398
40. Pene F Aubron C Azoulay E Blot F Thiery G Raynard B Schlemmer B Nitenberg G Buzyn A Arnaud P Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: A reappraisal of indications for organ failure supports J Clin Oncol 2006, 24:643-649. 10.1200/JCO.2005.03.9073 16380411
41. Rivers E Nguyen B Havstad S Ressler J Muzzin A Knoblich B Peterson E Tomlanovich M Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 2001, 345:1368-1377. 10.1056/ NEJMoa010307 11794169
42. Bergh J Wiklund T Erikstein B Lidbrink E Lindman H Malmstrom P Kellokumpu-Lehtinen P Bengtsson NO Soderlund G Anker G Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: A randomised trial. Scandinavian Breast Group 9401 study Lancet 2000, 356:1384-1391. 10.1016/S0140-6736(00)02841-5 11052580
43. Coiffier B Lepage E Briere J Herbrecht R Tilly H Bouabdallah R Morel P Van Den NE Salles G Gaulard P CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma N Engl J Med 2002, 346:235-242. 10.1056/NEJMoa011795 11807147
44. Annane D Sebille V Charpentier C Bollaert PE Francois B Korach JM Capellier G Cohen Y Azoulay E Troche G Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock JAMA 2002, 288:862-871. 10.1001/jama.288.7.862 12186604
45. Bernard GR Vincent JL Laterre PF LaRosa SP Dhainaut JF Lopez-Rodriguez A Steingrub JS Garber GE Helterbrand JD Ely EW Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 2001, 344:699-709. 10.1056/NEJM200103083441001 11236773